Historical salary details - Ms. Mary T. Szela, Independent Director, Kura Oncology Inc
Ms. Mary T. Szela is the Independent Director of Kura Oncology Inc. They also hold 1 other positions in and TriSalus Life Sciences Inc.
Ms. Mary T. Szela
Independent Director
$ 406.1 K
Gross Remuneration
-
Current Company
Kura Oncology Inc
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Kura Oncology Inc | Independent Director | 406.1 K | 45.1 % |
| 2024 | TriSalus Life Sciences Inc | Chief Executive Officer, President and Director | - | - |
| 2023 | Kura Oncology Inc | Independent Director | 279.8 K | -1.3 % |
| 2023 | Omega Therapeutics Inc | - | 153.7 K | 66.7 % |
| 2023 | TriSalus Life Sciences Inc | Chief Executive Officer, President and Director | - | - |
| 2022 | Kura Oncology Inc | Independent Director | 283.4 K | -22.7 % |
| 2022 | Omega Therapeutics Inc | Independent Director | 92.2 K | 208.8 % |
| 2022 | TriSalus Life Sciences Inc - Warrants (04/08/2028) | Chief Executive Officer, President and Director | - | - |
| 2022 | TriSalus Life Sciences Inc | Chief Executive Officer, President and Director | - | - |
| 2021 | Kura Oncology Inc | Independent Director | 366.6 K | 16.9 % |
| 2021 | Coherus Biosciences Inc | - | 243.7 K | -15.4 % |
| 2021 | Omega Therapeutics Inc | Independent Director | 29.9 K | - |
| 2021 | Alimera Sciences Inc. | - | 25 K | -61.1 % |
| 2021 | Coherus Biosciences Inc | Independent Director | - | - |
| 2021 | Alimera Sciences Inc. | Independent Director | - | - |
| 2020 | Kura Oncology Inc | Independent Director | 313.6 K | 53.9 % |
| 2020 | Coherus Biosciences Inc | Independent Director | 288.2 K | 27.3 % |
| 2020 | Alimera Sciences Inc. | Independent Director | 64.2 K | -14.7 % |
| 2020 | Omega Therapeutics Inc | Independent Director | - | - |
| 2019 | Coherus Biosciences Inc | Independent Director | 226.4 K | 20.9 % |
| 2019 | Kura Oncology Inc | Independent Director | 203.8 K | -31.7 % |
| 2019 | Alimera Sciences Inc. | Independent Director | 75.3 K | 69.4 % |
| 2018 | Kura Oncology Inc | Independent Director | 298.4 K | - |
| 2018 | Coherus Biosciences Inc | Independent Director | 187.3 K | -49.9 % |
| 2018 | Alimera Sciences Inc. | Independent Director | 44.4 K | - |
| 2017 | Coherus Biosciences Inc | Independent Director | 373.8 K | 116.6 % |
| 2017 | Novo Nordisk - ADR | Independent Director | - | - |
| 2016 | Novo Nordisk - ADR | Independent Director | 900 K | 0.0 % |
| 2016 | Coherus Biosciences Inc | Independent Director | 172.6 K | -57.4 % |
| 2015 | Novo Nordisk - ADR | Independent Director | 900 K | - |
| 2015 | Coherus Biosciences Inc | Independent Director | 404.7 K | 270.3 % |
| 2014 | Coherus Biosciences Inc | Independent Director | 109.3 K | - |
| 2013 | Coherus Biosciences Inc | Independent Director | - | - |